Treatment With Grazoprevir/Elbasvir for Renal Transplant Recipients With Chronic Hepatitis C Virus Infection and Impaired Allograft Function-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment With Grazoprevir/Elbasvir for Renal Transplant Recipients With Chronic Hepatitis C Virus Infection and Impaired Allograft Function

Published:2019-01 Issue:1 Volume:5 Page:e419
ISSN:2373-8731
Container-title:Transplantation Direct
language:en
Short-container-title:Transplantation Direct

Author:

Eisenberger Ute,Friebus-Kardash Justa,Guberina Hana,Kribben Andreas,Witzke Oliver,Willuweit Katharina,Gerken Guido,Herzer Kerstin

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference28 articles.

1. Telaprevir, boceprevir, cytochrome P450 and immunosuppressive agents—a potentially lethal cocktail;Hepatology,2011

2. Management of telaprevir-based triple therapy for hepatitis C virus recurrence post liver transplant;World J Hepatol,2015

3. EASL recommendations on treatment of hepatitis C 2016;J Hepatol,2017

4. ELITA consensus statements on the use of DAAs in liver transplant candidates and recipients;J Hepatol,2017

5. Elbasvir/grazoprevir use in postliver transplantation patients on hemodialysis;Transplantation,2017

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Systematic Review of Direct-Acting Antivirals for Hepatitis C in Advanced CKD;Kidney International Reports;2023-02

2. ‘Real-life’ experience with direct-acting antiviral agents for HCV after kidney transplant;Annals of Hepatology;2021-11

3. Treatment with Grazoprevir/Elbasvir in Post-kidney Transplant Patients with Hepatitis C Virus Genotype 4 Infection;Hepatitis Monthly;2021-06-02

4. Real-world direct-acting antiviral treatment in kidney transplant and hemodialysis patients: the EpiTer-2 multicenter observational study;Annals of Gastroenterology;2021

5. Pan-Genotype Pre-Exposure Prophylaxis (PrEP) Allows Transplantation of HCV-Positive Donor Kidneys to Negative Transplant Recipients;Journal of Clinical Medicine;2020-12-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3